drugset / Trial / NCT00485615
An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective is to evaluate the efficacy of an enteric-coated, eicosapentaenoic acid-concentrated fish oil in the treatment of social phobia. A secondary objective is to determine if treatment outcome is related to plasma phospholipid essential fatty acid status, niacin skin flush and measures of lipid/protein peroxidation.
Timeline
- Start
- 2008-10
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eicosapentaenoic acid | Small molecule | 1500 mg | — |
| Subject | Eicosapentaenoic acid | Small molecule | 3000 mg | — |